ABSTRACT
INTRODUCTION
The most widely used screening method for intrapartum hypoxia is electronic fetal heart rate monitoring. It has very poor specificity and positive predictive value for hypoxia and adverse neonatal outcome, and may indeed be considered a failure of public health policy 1 . Vulnerable fetuses often require rapid delivery by emergency Cesarean section (CS), which carries elevated maternal and fetal risks, and costs the healthcare system much more than vaginal delivery. The recent UK Royal College of Obstetricians and Gynaecologists' Each Baby Counts Report 2 reveals that 0.16% of all term babies born in 2015 died or suffered significant brain injury following the onset of labor. In conjunction with other recommendations, this report highlights the need for continuous risk assessment commencing in the antenatal period and continuing intrapartum. The current challenge is therefore to identify vulnerable fetuses at risk of hypoxic complications, particularly within an apparently low-risk cohort before the onset of labor.
The cerebroplacental ratio (CPR) is an independent predictor of intrapartum fetal compromise (IFC), acidosis at birth and neonatal intensive care unit admission in term babies that are not small-for-gestational age (SGA) 3, 4 . There is also emerging evidence that low maternal placental growth factor (PlGF) level is associated with suboptimal placental function and fetal growth restriction 5 , as well as an increased risk of term IFC (fetal distress) requiring emergency operative delivery, low birth weight, and poorer neonatal outcome 6 .
The primary aim of this proof-of-concept pilot study was thus to investigate the combined screening performance of CPR and maternal PlGF for the prediction of CS for IFC in low-risk term pregnancy. The secondary outcome was the prediction of composite adverse neonatal outcome (CANO). Finally, we sought to identify the best CPR and PlGF thresholds and their subsequent screening performance for the prediction of CS for IFC and CANO in a low-risk population.
SUBJECTS AND METHODS
This was a prospective cohort study conducted at Mater Mother's Hospital, Brisbane, Australia. Low-risk women with uncomplicated singleton pregnancy who were planning a vaginal delivery were invited to participate in the study when they attended for routine antenatal appointments. Those with a known SGA fetus, age > 40 years, diabetes mellitus, hypertension, pre-eclampsia or fetal malformation were excluded from the study. Written informed consent was obtained at enrolment from all women. Ethical and governance approvals were granted by the relevant committees prior to recruitment (Ref: HREC/13/MHS/173).
All pregnancies were dated according to crown-rump length measurement in the first trimester. Women attended fortnightly for CPR and PlGF measurement from 36 ± 1 weeks' gestation until delivery, with the last measurement prior to birth used for the analysis. For CPR, umbilical artery pulsatility index (UA-PI) and fetal middle cerebral artery PI (MCA-PI) were recorded in triplicate during fetal quiescence over a minimum of three cardiac cycles. CPR (MCA-PI/UA-PI) was calculated as reported previously 7 . Fetal biometry and estimated fetal weight, according to Hadlock's formula 8 , were recorded. PlGF assays were performed on maternal venous samples. All participants were analyzed using the Triage PlGF Test (Alere, San Diego, CA, USA), which reports concentrations in the range of 12-3000 pg/mL with an overall coefficient of variation of 12.8-13.2%. Quality control was performed in accordance with the manufacturer's recommendations.
Labor and delivery were managed according to institutional protocols and guidelines. Participants and clinicians were blinded to ultrasound results, except in cases in which malpresentation, severe oligohydramnios (deepest vertical pocket < 1 cm) or absent/reversed end-diastolic flow in the UA was detected. If any of these abnormalities was detected, obstetric caregivers were informed immediately, as these findings would alter clinical management, and the participant was excluded from the final analysis. Participants and clinicians were blinded to PlGF results, as were the investigators at the time of the ultrasound examination. Intrapartum fetal heart rate patterns were classified by the treating birth suite obstetric team according to criteria detailed in the Royal Australian College of Obstetricians and Gynaecologists' guidelines 9 . These are very similar to guidelines used in the UK 10 and USA 11 . The primary outcome was CS for IFC. The secondary outcome, CANO, was defined as a composite of severe acidosis (pH ≤ 7.0 or base excess ≤ −12 and/or lactate ≥ 6.5 mmol/L), low Apgar score (≤ 5 at 5 min) and/or stay in the neonatal intensive care unit (NICU) for ≥ 48 h. The diagnosis of IFC was made contemporaneously by the treating obstetrician based on abnormal fetal heart rate patterns and/or high fetal scalp lactate level (> 4 mmol/L). Intrapartum and neonatal outcomes were collected within 72 h of delivery.
Statistical analysis
The associations between continuous variables were assessed using scatterplots and pairwise correlations. Normally distributed data are reported as mean ± SD. Non-normally distributed data are reported as median and interquartile range (IQR). Comparisons between groups of non-normally distributed data were tested using Wilcoxon rank-sum test and Kruskal-Wallis test. The two independent samples t-test or Student's t-test was used to compare normally distributed data. The chi-square test or Fisher's exact test was used to test for relationships between categorical variables.
Gestational age-related reference centiles for CPR and PlGF were derived from study subjects, excluding those who had a delivery for IFC (CS or instrumental) or adverse neonatal outcome. For CPR centiles, the reference group was drawn from a larger study of which this study forms a subgroup. For PlGF centile calculation, the reference group was drawn only from the current study group; thus, the PlGF reference group is a subset of the CPR reference group.
Altman's method was used to adjust for the normal decrease and change in SD of CPR and PlGF from 36 weeks of gestation to term 12 . Over this period, changes in the CPR and PlGF were linear. PlGF was logarithmically transformed for centile calculation.
The screening performance of CPR and PlGF, individually and combined, was first evaluated with CPR and PlGF expressed as continuous variables in centiles according to gestational age. Logistic regression was used to assess any association between CPR and/or PlGF and the outcome variables CS for IFC and CANO, and to estimate the area under the receiver-operating characteristics curve (AUC). Secondly, scatterplots were used to identify the appropriate CPR and PlGF cut-offs to achieve 100% sensitivity for the prediction of CS for IFC. These cut-offs were then applied to create binary variables to calculate screening performance (sensitivity, specificity, positive (LR+) and negative (LR-) likelihood ratios and positive (PPV) and negative (NPV) predictive values).
The significance level for all analyses was set at P ≤ 0.05. Statistical analysis was performed using Stata ® , Release 13 statistical analysis program for Windows (StataCorp LP, College Station, TX, USA). This study was conducted in accordance with the STARD guidelines 13 .
RESULTS
A total of 264 women consented to participate in the study. Following exclusions (n = 57) for various reasons, 207 women were included in the final analysis ( Figure 1 ). The participant characteristics of the final study cohort and the comparison between those who delivered by CS for IFC and those who did not are presented in Table 1 . The characteristics of women in the CS for IFC group did not differ significantly from those in the rest of the study participants. In the final cohort, seven (3.4%) women delivered by CS for IFC, and 38 (18.4%) had an infant with CANO. The median interval between the final assessment and birth was 8 (IQR, 5-12) days for the overall cohort, and did not differ significantly between those who did and those who did not have CS for IFC, or between those with and those without CANO for women who went into labor spontaneously. The summary of CPR, PlGF and intrapartum and neonatal outcomes in the entire cohort, grouped by CS for IFC and by CANO, are presented in Table 2 .
Cesarean section for intrapartum fetal compromise
Pregnancies delivered by CS for IFC had significantly lower mean CPR and median PlGF than the rest of the study cohort (Table 2) . Compared with the rest of the study cohort, a greater proportion of pregnancies delivered by CS for IFC had intrapartum fetal heart rate abnormality, were acidotic and had CANO (Table 2) . Babies delivered by CS for IFC had lower absolute birth weight and birth-weight centile, and a higher proportion had birth weight < 10 th centile, although these differences were not significant (P = 0.06, P = 0.07 and P = 0.30, respectively).
The AUC for the individual and combined screening performances of CPR and PlGF centiles as continuous variables for the prediction of CS for IFC are presented in Figure 2 . The highest AUC for the prediction of CS for IFC (0.92; 95% CI, 0.86-0.97) was achieved by the model combining CPR and PlGF. This model resulted in a significantly higher AUC than that for PlGF in isolation (P = 0.007), however, this was not the case when compared with the AUC for CPR in isolation (P = 0.13).
CPR and PlGF cut-off centiles achieving 100% sensitivity for the prediction of CS for IFC were the 20 Potentially eligible participants (n = 264) Excluded (n = 52):
Figure 1 Flowchart of study participants. *Cerebroplacental ratio (CPR) measurement considered an outlier. CS, Cesarean section; FHR, fetal heart rate; IFC, intrapartum fetal compromise; PlGF, placental growth factor. Data are given as mean ± SD, median (interquartile range) or n (%). *Vacuum or forceps delivery. †Induction of labor cases excluded. ‡Wilcoxon rank-sum (Mann-Whitney) test. §Fisher's exact test. ¶Chi-square test. **Student's t-test. † †Labor duration recorded in only one patient. BW, birth weight; CANO, composite adverse neonatal outcome (severe acidosis, low Apgar score and/or NICU admission); CPR, cerebroplacental ratio; CS, Cesarean section; EFW, estimated fetal weight; FHR, fetal heart rate; GA, gestational age; IFC, intrapartum fetal compromise; NICU, neonatal intensive care unit; PlGF, placental growth factor; VD, vaginal delivery. 
Figure 3
Cerebroplacental ratio (CPR) and placental growth factor (PlGF) centiles in 207 low-risk term pregnancies, for those that were ( ) and those that were not ( ) delivered by Cesarean section for intrapartum fetal compromise. Dashed lines represent centiles at which sensitivity is 100%. CPR reference values for the 20 th centile in weekly increments from 36 + 0 to 40 + 6 weeks were: 1.74 at 36 + 0 to 36 + 6 weeks, 1.62 at 37 + 0 to 37 + 6 weeks, 1.55 at 38 + 0 to 38+ 6 weeks, 1.46 at 39 + 0 to 39 + 6 weeks and 1.43 at 40 + 0 to 40 + 6 weeks. The corresponding predicted values for the 33 rd centile of PlGF were approximately: 111 pg/mL at 36 + 0 to 36 + 6 weeks, 95 pg/mL at 37 + 0 to 37 + 6 weeks, 81 pg/mL at 38 + 0 to 38 + 6 weeks, 60 pg/mL at 39 + 0 to 39 + 6 weeks and 64 pg/mL at 40 + 0 to 40 + 6 weeks.
The screening performance of the CPR 20 th and PlGF 33 rd centile thresholds for the prediction of CS for IFC are presented in Table 3 . The highest specificity and LR+ were achieved by CPR and PlGF in combination.
Composite adverse neonatal outcome
Median PlGF concentration and PlGF centile were significantly lower in pregnancies with compared with those without CANO ( Table 2) . A greater proportion of fetuses that had CANO had meconium stained amniotic fluid, had intrapartum fetal heart rate abnormalities, were female and required instrumental delivery or CS for IFC. Fetuses with CANO had a median gestational age at birth 3.5 days greater and a lower birth-weight centile than those without (Table 2) .
Regression analysis of CPR and PlGF centiles as continuous variables for the prediction of CANO showed that the highest AUC (0.64; 95% CI, 0.54-0.74) was achieved by the combination of CPR and PlGF, exceeding the AUC of CPR (0.59; 95% CI, 0.49-0.70) and PlGF (0.62; 95% CI, 0.51-0.72) in isolation. However, the combined model's AUC was not significantly higher than that of either CPR or PlGF in isolation (P = 0.29 or P = 0.43, respectively).
The screening performance of CPR 20 th and PlGF 33 rd centile thresholds for the prediction of CANO is presented in Table 3 . The highest specificity and LR+ for CANO were again achieved by CPR 20 th and PlGF 33 rd centiles in combination.
DISCUSSION
This study demonstrates that low CPR and maternal PlGF level are associated with, and are predictive of, CS for IFC. Furthermore, the AUC was highest when CPR and PlGF were used in combination, reaching a value of 0.92. The AUC values are considerably higher than those reported for intrapartum fetal heart rate monitoring (0.60-0.63) 14 , which is currently used to screen for intrapartum fetal compromise. CPR 20 th and PlGF 33 rd centile cut-offs in combination produce sensitivity of 100%, specificity of 86% and LR+ of 7.14, albeit at a false-positive rate (FPR) of 14%. The low-risk profile of our study sample is confirmed by the low prevalence of fetuses with estimated fetal weight < 10 th centile (4.8%). Unfortunately, the low number of these fetuses precluded assessment of test performance within this at-risk group.
Our findings add to the growing body of research indicating that both prelabor hemodynamic evidence of suboptimal fetal growth 4, 15, 16 and subtle placental dysfunction 6 are already evident in apparently low-risk pregnancies, and that this predisposes these apparently normally grown babies to intrapartum compromise and adverse neonatal outcome. The key difference between the current and previous studies is the prospective nature combined with the low-risk profile of the cohort. To date, much of the published data regarding CPR and PlGF have been retrospective and from at-risk groups, such as pregnancies affected by pre-eclampsia, small-for-gestational age and/or fetal growth restriction. However, because of the higher risk profile of these groups, they naturally have higher rates of intrapartum intervention 17 and adverse neonatal sequelae 18 . A FPR of 14% is acceptable in our view given the potential significance of complications related to intrapartum hypoxia and its longer-term sequelae. Indeed, a FPR exceeding 10% has precedence in other areas of obstetrics and medicine. The mainstay of intrapartum fetal wellbeing assessment, fetal heart rate monitoring, has a reported FPR of 60% for detection of fetal hypoxia 19 and up to 99.8% for cerebral palsy, yet it is used almost ubiquitously throughout the world 20 . Screening for breast cancer using mammography yields a 62% cumulative 10-year FPR 21 , whilst screening for prostate cancer (amongst men with elevated prostatic specific antigen who then underwent biopsy) has a reported FPR of 75.9% 22 . In oncology, invasive testing following a screen-positive result is offered routinely to make the diagnosis, a procedure that carries a higher risk of complication and arguably provokes greater anxiety than induction of labor. Induction of labor is the current management for a fetus at term with concerns for fetal wellbeing. The DIGITAT 23 randomized trial has shown that induction does not increase the risk of adverse perinatal outcome. If we take a similar approach to screening for intrapartum fetal compromise, which can result in lifelong neurological disability, to that used in cancer screening, we propose that a 14% FPR is acceptable and a significant improvement on currently used techniques.
For the calculation of CPR and PlGF reference centiles, we chose to exclude cases with IFC and adverse neonatal outcome. The rationale for this is that inclusion of cases with these events would have artificially skewed and lowered the centile values. As the aim of centile creation is to use or define a cohort with truly normal outcomes, our approach was felt to be justified.
Limitations of this study include the relatively low prevalence of CS for IFC, the tertiary setting and the use of conventional electronic fetal heart monitoring for the diagnosis of IFC or hypoxia. Whilst strict criteria were used for CANO, some may contest that CANO does not represent the natural history as it may be influenced by the operative intervention itself. The benefits of any intervention once a high-risk pregnancy was identified were not assessed, given the level of evidence to date. The positive likelihood ratios, whilst seemingly modest, need to be viewed in the context of a low-risk screened population and are likely to be substantially greater in a higher-risk cohort. A higher-risk group will naturally have a greater prevalence of an adverse event and thus the performance of any screening test will be improved 24 . In pregnancy, however, low-risk women constitute by far the largest cohort in which the majority of cases of intrapartum fetal hypoxia occur 25 , despite a relatively low prevalence of disease.
Currently, identification of at-risk term fetuses is problematic. Cochrane systematic reviews have shown that no effective screening or risk stratification strategies currently exist for low-risk women at term [26] [27] [28] [29] . Furthermore, reviews 28, 29 of conventional antepartum cardiotocography, computerized fetal heart rate analysis and intermittent auscultation have reported no improvement in perinatal outcome. Electronic fetal heart rate monitoring has poor characteristics as a test, with subjective interpretation and poor intra-and interobserver agreement 30 . It also lacks discriminatory power to identify truly hypoxic fetuses. Notwithstanding these concerns, we acknowledge that, in this study, electronic fetal heart rate monitoring in conjunction with fetal scalp lactate was used as the basis for the initial diagnosis of fetal compromise and indeed the indication for the operative birth itself. Whilst this may seem contradictory in terms, we felt that this approach was justified given the absence of a gold standard for the detection of intrapartum fetal hypoxia and the need for a real-world pragmatic approach to an important clinical problem.
Although we found that CPR and maternal PlGF improved the overall predictive utility for CS for IFC and CANO, it is important to note that there was no statistical difference in AUC between the combined model and CPR alone for either outcome, or between the combined model and CPR or PlGF in isolation for CANO. Given the relative ease of performing an ultrasound assessment in late pregnancy vs the costs and logistics associated with maternal PlGF assays, it is debatable whether the addition of maternal PlGF to any screening algorithm is at this stage cost-effective. It may be that the true benefit of a combined test is its utility to rule out the likelihood of an adverse event whilst improving test performance for those who are screen-positive, and thus tailoring intrapartum management appropriately.
The ability to screen a low-risk population to identify pregnancies at risk of intrapartum hypoxic compromise and provide an individualized risk assessment and timely discussion regarding timing, place and mode of birth would provide significant improvement to obstetric care. It is a necessary first step before the benefits, including an evaluation of cost-effectiveness, of any intervention are assessed.
